Fundraising Fox

TransVoyant

Alexandria, US · Delaware corporation · 1 known investors

Founders & leadership

DG
Dennis GrosecloseFounder
SS
Shariar ShahidiExecutive
DM
Dawn MoratExecutive
JC
James ClauticeExecutive

Board

PM
Patrick McPhersonBoard director
JV
Joseph VolpeBoard director
TF
Timothy FleischerBoard director

Investors · 1

Merck Global Health Innovation Fundreported · 2 sourcesRahway

Reported raises · per SEC filings

Form D private placements

$18M disclosed across 6 rounds · 2016–2023

▶$8.7MraisedFeb 2026 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shariar ShahidiExecutive Officer
  • Dawn MoratExecutive Officer
  • Dennis GrosecloseExecutive Officer, Director
  • Joseph VolpeDirector
  • Timothy FleischerDirector
Offering amount
$25M
Amount sold
$8.7M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.2MraisedMay 2023 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dawn MoratExecutive Officer
  • Dennis GrosecloseExecutive Officer, Director
  • Timothy FleischerExecutive Officer, Director
  • Joseph VolpeDirector
  • Shariar ShahidiExecutive Officer
Offering amount
$6.2M
Amount sold
$3.2M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedAug 2019 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick McPhersonDirector
  • Shariar ShahidiExecutive Officer
  • Dawn MoratExecutive Officer
  • Dennis GrosecloseExecutive Officer, Director
  • Timothy FleischerExecutive Officer, Director
  • David PanitzExecutive Officer
Offering amount
$6M
Amount sold
$2M
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMar 2019 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis GrosecloseExecutive Officer, Director
  • Timothy FleischerExecutive Officer, Director
  • Shariar ShahidiExecutive Officer
  • Patrick McPhersonDirector
  • Dawn MoratExecutive Officer
  • David PanitzExecutive Officer
Offering amount
$500K
Amount sold
$500K
First sale
Feb 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedJun 2017 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • James ClauticeExecutive Officer
  • Scott ByrnesExecutive Officer
  • Timothy FleischerExecutive Officer, Director
  • Patrick McPhersonDirector
  • Dennis GrosecloseExecutive Officer, Director
  • David PanitzExecutive Officer
Offering amount
$5.4M
Amount sold
$500K
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedMar 2017 · 18 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis GrosecloseExecutive Officer, Director
  • Patrick McPhersonDirector
  • James ClauticeExecutive Officer
  • Timothy FleischerExecutive Officer, Director
Offering amount
$3.7M
Amount sold
$3.1M
First sale
Jun 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

TransVoyant raises millions in funding for AI-based supply chain software, with hopes to double in size - Washington Business Journalbizjournals.com · Jun 2023TransVoyant Raises Funding from Merck Global Health Innovation Fund and P74 Venturesfinsmes.com · Dec 2022Merck Global Health Innovation Fund and P74 Ventures Make Strategic Investment in TransVoyant for Intelligent, ‘Self Aware’ Supply Chain Platformbusinesswire.com · Dec 2022TransVoyant raises millions in funding for AI-based supply chain software, with hopes to double in sizebiztoc.com

Frequently asked questions

Who founded TransVoyant?
TransVoyant was founded by Dennis Groseclose.
Who are TransVoyant's investors?
TransVoyant's investors include Merck Global Health Innovation Fund.
How much funding has TransVoyant raised?
TransVoyant has disclosed $18M raised across 6 rounds.
Where is TransVoyant headquartered?
TransVoyant is headquartered in Alexandria, US.